Citation Impact
1 by Nobel laureates 4 from Science/Nature 63 standout
Citing Papers
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Works of Bob An being referenced
Effects of liraglutide (NN2211), a long‐acting GLP‐1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes
2005
The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose
2003
Author Peers
| Author | Physiology | PRM | Pharmacology | EDM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| Bob An | 44 | 93 | 58 | 332 | 194 | 6 | 432 | |
| V. Colamaria | 37 | 29 | 8 | 83 | 25 | 492 | ||
| Carl M. Hand | 11 | 424 | ||||||
| Lars‐Oliver Tykocinski | 50 | 34 | 5 | 104 | 26 | 21 | 776 | |
| C F Bekdik | 22 | 287 | 7 | 86 | 180 | 54 | 795 | |
| Joseph C. Ballenger | 15 | 231 |
All Works
Loading papers...